These antidiabetic agents regulate blood glucose through various mechanisms, such as improving insulin sensitivity, promoting insulin secretion, and delaying gastric emptying, while also reducing the severity of fatty liver (9, 10). The gene discussed is INS; the disease is Hepatic steatosis.